View in EDS HTML Full Text PDF Full Text

Baseline Radiomics as a Prognostic Tool for Clinical Benefit from Immune Checkpoint Inhibition in Inoperable NSCLC Without Activating Mutations.

Saved in:
Bibliographic Details
Title: Baseline Radiomics as a Prognostic Tool for Clinical Benefit from Immune Checkpoint Inhibition in Inoperable NSCLC Without Activating Mutations.
Authors: Moiseenko, Fedor1,2 (AUTHOR), Radulovic, Marko2,3 (AUTHOR) markoradulovic@gmail.com, Tsvetkova, Nadezhda1,3 (AUTHOR), Chernobrivceva, Vera1,4 (AUTHOR), Gabina, Albina1,2 (AUTHOR), Oganesian, Any1,2,4 (AUTHOR), Makarkina, Maria1,3 (AUTHOR), Elsakova, Ekaterina1,4 (AUTHOR), Krasavina, Maria1 (AUTHOR), Barsova, Daria1 (AUTHOR), Artemeva, Elizaveta1 (AUTHOR), Khenshtein, Valeria1 (AUTHOR), Levchenko, Natalia1 (AUTHOR), Chubenko, Viacheslav1 (AUTHOR), Egorenkov, Vitaliy1 (AUTHOR), Volkov, Nikita1 (AUTHOR), Bogdanov, Alexei1 (AUTHOR), Moiseyenko, Vladimir1 (AUTHOR)
Source: Cancers. Jun2025, Vol. 17 Issue 11, p1790. 16p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:20726694
DOI:10.3390/cancers17111790